US 12,344,604 B2
Imidazolonylquinoline compounds and therapeutic uses thereof
Thomas Fuchss, Bensheim-Auerbach (DE); Axel Becker, Seeheim-Jugenheim (DE); Holger Kubas, Bad Homburg (DE); and Ulrich Graedler, Weinheim (DE)
Assigned to Merck Patent GmbH, Darmstadt (DE)
Appl. No. 17/442,703
Filed by Merck Patent GmbH, Darmstadt (DE)
PCT Filed Mar. 25, 2020, PCT No. PCT/EP2020/058425
§ 371(c)(1), (2) Date Sep. 24, 2021,
PCT Pub. No. WO2020/193660, PCT Pub. Date Oct. 1, 2020.
Claims priority of application No. 19165664 (EP), filed on Mar. 27, 2019.
Prior Publication US 2022/0144828 A1, May 12, 2022
Int. Cl. C07D 471/04 (2006.01); A61P 35/00 (2006.01)
CPC C07D 471/04 (2013.01) [A61P 35/00 (2018.01); C07B 2200/05 (2013.01)] 8 Claims
 
1. A compound, represented by the following formula

OG Complex Work Unit Chemistry
or pharmaceutically acceptable salt thereof.